IP Library › Granted Patent US 10,202,430
Granted Patent B2
US 10,202,430 · App. 12/738,774 · Granted Feb 12, 2019

IgM-mediated receptor clustering and cell modulation

Inventors: Larry R. Pease (Rochester, MN); Moses Rodriguez (Rochester, MN)
Assignee: MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH
C07K14/4726
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,202,430
App. No.
12/738,774
Granted
Feb 12, 2019
Kind
B2
Abstract

Materials and methods for using multivalent molecules (e.g., antibodies) to modulate cellular function. A molecule can be targeted to a particular type of cell, either through direct binding to an epitope on the surface of the cell, or through a linker that recognizes both the multivalent molecule and a marker on the cell surface. The invention provides a chimeric polypeptide comprising a first amino acid sequence and a second amino acid sequence, wherein the first amino acid sequence comprises an WIC Class I peptide sequence, and where the second amino acid sequence comprises an epitope to which a multivalent molecule binds, including wherein the multivalent molecule is an IgM antibody, including antibody hIgM22. The invention provides a linker molecule for targeting IgM antibody, including antibody hIgM22, to a cell in the oligodendrocyte lineage.

Claims (3)

1. A chimeric polypeptide comprising a first amino acid sequence and a second amino acid sequence, wherein the first amino acid sequence comprises an MEW Class I peptide Kb amino acid sequence, and where the second amino acid sequence comprises an epitope to which a multivalent molecule binds, wherein the multivalent molecule is an IgM antibody hIgM22 and the second amino acid sequence comprises SEQ ID NO: 3.

2. A linker molecule for targeting IgM antibody hIgM22 to a cell in the oligodendrocyte lineage, wherein the linker molecule is a polypeptide comprising (i) an amino acid sequence SEQ ID NO: 3 comprising an epitope to which hIgM22 specifically binds and (ii) an amino acid sequence that binds specifically to an epitope or marker on the surface of the cell in the oligodendrocyte lineage.

3. The linker molecule of claim 2 wherein the cell is an oligodendrocyte.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 7, 2010
From: PEASE, LARRY R.; RODRIGUEZ, MOSES
To: MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH
Reel/Frame 024354/0280 →
Continuity (2)
Provisional Application 60999403 · Oct 18, 2007
Related Publication 20100291675A1 · Nov 18, 2010